New chemo combo aims to keep liver cancer from coming back after surgery
NCT ID NCT07570914
First seen May 09, 2026 · Last updated May 16, 2026 · Updated 1 time
Summary
This study tests a treatment for people whose colorectal cancer spread to the liver and was surgically removed. After surgery, participants get a liver-directed chemo drip plus standard chemo pills and IV drugs for 2 to 4 cycles. The goal is to see if this combination helps keep the cancer from returning for at least 3 years. About 28 adults aged 18 to 75 with no signs of remaining cancer after surgery will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.